Synthesis, antiviral and cytostatic activities of carbocyclic nucleosides incorporating a modified cyclopentane ring. Part 2: Adenosine and uridine analogues. 1998

M I Nieto, and J M Blanco, and O Caamaño, and F Fernández, and X García-Mera, and J Balzarini, and E Padalko, and J Neyts, and E De Clercq
Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago, Spain.

Six new carbocyclic nucleosides were prepared by mounting a purine (compounds 5-7), 8-azapurine (compounds 9 and 10) or pyrimidine (compound 13) base on the amino group of (1R,cis)-3-(aminomethyl)-1,2,2-trimethylcyclopentylmethanol (2). The antiviral activity of compounds 5-7, 10 and 13, and their cytostatic activity, were evaluated. At subtoxic concentrations, the compounds showed no or marginal antiviral activity. Compound 5 showed moderate inhibition on tumor cell proliferation.

UI MeSH Term Description Entries
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D003517 Cyclopentanes A group of alicyclic hydrocarbons with the general formula R-C5H9. Cyclopentadiene,Cyclopentadienes,Cyclopentene,Cyclopentenes,Cyclopentane
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D014498 Uracil One of four nucleotide bases in the nucleic acid RNA.
D014529 Uridine A ribonucleoside in which RIBOSE is linked to URACIL. Allo-Uridine,Allouridine,Allo Uridine

Related Publications

M I Nieto, and J M Blanco, and O Caamaño, and F Fernández, and X García-Mera, and J Balzarini, and E Padalko, and J Neyts, and E De Clercq
January 2002, Nucleosides, nucleotides & nucleic acids,
M I Nieto, and J M Blanco, and O Caamaño, and F Fernández, and X García-Mera, and J Balzarini, and E Padalko, and J Neyts, and E De Clercq
September 2003, Chemical & pharmaceutical bulletin,
M I Nieto, and J M Blanco, and O Caamaño, and F Fernández, and X García-Mera, and J Balzarini, and E Padalko, and J Neyts, and E De Clercq
October 1999, Archiv der Pharmazie,
M I Nieto, and J M Blanco, and O Caamaño, and F Fernández, and X García-Mera, and J Balzarini, and E Padalko, and J Neyts, and E De Clercq
August 1997, Archiv der Pharmazie,
M I Nieto, and J M Blanco, and O Caamaño, and F Fernández, and X García-Mera, and J Balzarini, and E Padalko, and J Neyts, and E De Clercq
September 2001, Chemical & pharmaceutical bulletin,
M I Nieto, and J M Blanco, and O Caamaño, and F Fernández, and X García-Mera, and J Balzarini, and E Padalko, and J Neyts, and E De Clercq
July 1998, Nucleosides & nucleotides,
M I Nieto, and J M Blanco, and O Caamaño, and F Fernández, and X García-Mera, and J Balzarini, and E Padalko, and J Neyts, and E De Clercq
October 1990, Chemical & pharmaceutical bulletin,
M I Nieto, and J M Blanco, and O Caamaño, and F Fernández, and X García-Mera, and J Balzarini, and E Padalko, and J Neyts, and E De Clercq
February 1983, Journal of medicinal chemistry,
M I Nieto, and J M Blanco, and O Caamaño, and F Fernández, and X García-Mera, and J Balzarini, and E Padalko, and J Neyts, and E De Clercq
September 1999, Chemical & pharmaceutical bulletin,
M I Nieto, and J M Blanco, and O Caamaño, and F Fernández, and X García-Mera, and J Balzarini, and E Padalko, and J Neyts, and E De Clercq
June 2002, Journal of medicinal chemistry,
Copied contents to your clipboard!